Cel-Sci Corp

Penny Stocks Biotech Stocks Healthcare Stocks

$1.24

+0.04 (+3.33%)

As of May 16, 2:21 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 4 80%

Hold 1 20%

Sell 0 0%

Price Target

Analyst Price Target +3,562.9% upside

Low Target $30.66

Average Target $45.42

High Target $56.99

Current Price $1.24

Current
$1.24

Target
$45.42

$30.66 $45.42 avg $56.99

Scenario Analysis

Bear Case

$30.66

2,372.6%

Low target

Base Case

$45.42

+3,562.9%

Avg target

Bull Case

$56.99

+4,496.0%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$13.48

-90.8% from high

52-Week Low

$0.89

+39.3% from low

Target vs 52W High

$45.42

+236.9% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%